Zealand Pharma A/S
CSE:ZEAL

Watchlist Manager
Zealand Pharma A/S Logo
Zealand Pharma A/S
CSE:ZEAL
Watchlist
Price: 362.2 DKK -1.12% Market Closed
Market Cap: 25.7B DKK

Relative Value

The Relative Value of one ZEAL stock under the Base Case scenario is hidden DKK. Compared to the current market price of 362.2 DKK, Zealand Pharma A/S is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ZEAL Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
14
vs Industry
5
Median 3Y
116.5
Median 5Y
74.1
Industry
7.5
Forward
6.6
vs History
vs Industry
Median 3Y
-22.8
Median 5Y
-13.8
Industry
23.6
Forward
53.7
vs History
vs Industry
Median 3Y
-23.5
Median 5Y
-14.5
Industry
20.2
vs History
vs Industry
Median 3Y
-20.4
Median 5Y
-11.4
Industry
22.9
vs History
96
vs Industry
20
Median 3Y
9.6
Median 5Y
6.7
Industry
2.8
vs History
14
vs Industry
5
Median 3Y
112.2
Median 5Y
73.2
Industry
7.7
Forward
4.5
vs History
14
vs Industry
3
Median 3Y
95
Median 5Y
58.8
Industry
9.6
vs History
vs Industry
Median 3Y
-18
Median 5Y
-13.6
Industry
4.9
Forward
30.8
vs History
vs Industry
Median 3Y
-17.7
Median 5Y
-12.9
Industry
4.9
Forward
2.9
vs History
vs Industry
Median 3Y
-20.5
Median 5Y
-12.7
Industry
5.4
vs History
vs Industry
Median 3Y
-20.2
Median 5Y
-12.2
Industry
4
vs History
31
vs Industry
8
Median 3Y
54.5
Median 5Y
38.1
Industry
5.1

Multiples Across Competitors

ZEAL Competitors Multiples
Zealand Pharma A/S Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
DK
Zealand Pharma A/S
CSE:ZEAL
25.6B DKK 459.7 -21.6 -12.7 -12.4
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 932 910.7 -161 278.1 -195 843 -193 608.2
US
Abbvie Inc
NYSE:ABBV
337.7B USD 5.9 81.3 15.4 22.8
US
Amgen Inc
NASDAQ:AMGN
159.4B USD 4.7 26.9 14.4 23.8
US
Gilead Sciences Inc
NASDAQ:GILD
139.6B USD 4.9 23.4 10.2 14
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
121.6B USD 11 -122.9 26.2 27.4
US
Epizyme Inc
F:EPE
94.1B EUR 2 076.1 -529.8 -576.9 -561.5
AU
CSL Ltd
ASX:CSL
117B AUD 5.1 28 17.3 21.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
62B USD 4.4 13.8 12.4 13.9
US
Seagen Inc
F:SGT
39.3B EUR 20 -61.3 -66.1 -59.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
41.4B USD 17.6 -153.6 -688.6 -345
P/S Multiple
Revenue Growth P/S to Growth
DK
Zealand Pharma A/S
CSE:ZEAL
Average P/S: 3 085 047.3
459.7
205%
2.2
FR
Pharnext SCA
OTC:PNEXF
33 932 910.7
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.9
8%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.7
4%
1.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.9
3%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
11
10%
1.1
US
E
Epizyme Inc
F:EPE
2 076.1
N/A N/A
AU
CSL Ltd
ASX:CSL
5.1
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
4.4
4%
1.1
US
S
Seagen Inc
F:SGT
20
30%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
17.6
30%
0.6
P/E Multiple
Earnings Growth PEG
DK
Zealand Pharma A/S
CSE:ZEAL
Average P/E: 34.7
Negative Multiple: -21.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -161 278.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
81.3
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
26.9
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
23.4
189%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -122.9 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -529.8 N/A N/A
AU
CSL Ltd
ASX:CSL
28
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.8
7%
2
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.3 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -153.6 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
DK
Zealand Pharma A/S
CSE:ZEAL
Average EV/EBITDA: 16
Negative Multiple: -12.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 843 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.4
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.4
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.2
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -576.9 N/A N/A
AU
CSL Ltd
ASX:CSL
17.3
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.4
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.1 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -688.6 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
DK
Zealand Pharma A/S
CSE:ZEAL
Average EV/EBIT: 20.6
Negative Multiple: -12.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 608.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.8
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.8
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
14
11%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
27.4
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -561.5 N/A N/A
AU
CSL Ltd
ASX:CSL
21.6
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.9
11%
1.3
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.6 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -345 N/A N/A